Key Points
- Director Esteban Lopez sold 150 shares on Dec. 15 at an average price of $115.18 for $17,277, reducing his stake to 3,700 shares (a 3.9% decline); he also sold 166 shares on Dec. 5 at $112.78.
- Recent results beat estimates: Addus reported Q3 EPS of $1.56 vs. a $1.53 consensus and revenue of $362.3M vs. $354.48M, with revenue up 25% year‑over‑year.
- Analyst and ownership landscape: The stock carries a "Moderate Buy" consensus with an average price target of $137.11, and roughly 95% of shares are held by institutions.
Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) Director Esteban Lopez sold 150 shares of the stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $115.18, for a total transaction of $17,277.00. Following the sale, the director directly owned 3,700 shares in the company, valued at approximately $426,166. This represents a 3.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Esteban Lopez also recently made the following trade(s):
- On Friday, December 5th, Esteban Lopez sold 166 shares of Addus HomeCare stock. The stock was sold at an average price of $112.78, for a total value of $18,721.48.
Addus HomeCare Stock Performance
Shares of ADUS stock opened at $113.49 on Wednesday. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.66 and a quick ratio of 1.66. The stock has a market cap of $2.10 billion, a PE ratio of 24.30, a price-to-earnings-growth ratio of 1.54 and a beta of 0.94. The stock has a 50-day moving average of $115.87 and a 200-day moving average of $113.84. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.53 by $0.03. The business had revenue of $362.30 million for the quarter, compared to analyst estimates of $354.48 million. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. Addus HomeCare's quarterly revenue was up 25.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.30 EPS. As a group, sell-side analysts expect that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of research firms recently commented on ADUS. TD Cowen upped their price objective on shares of Addus HomeCare from $139.00 to $140.00 and gave the company a "buy" rating in a research report on Wednesday, November 5th. UBS Group began coverage on Addus HomeCare in a report on Tuesday, September 2nd. They issued a "buy" rating and a $145.00 price target for the company. Barclays lifted their price objective on Addus HomeCare from $111.00 to $117.00 and gave the company an "underweight" rating in a report on Tuesday, November 4th. Stephens reiterated an "overweight" rating and issued a $140.00 price objective on shares of Addus HomeCare in a research report on Wednesday, September 3rd. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of Addus HomeCare in a research note on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $137.11.
Get Our Latest Report on ADUS
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of ADUS. Vanguard Group Inc. raised its position in Addus HomeCare by 2.9% in the 3rd quarter. Vanguard Group Inc. now owns 1,298,104 shares of the company's stock valued at $153,163,000 after buying an additional 36,674 shares during the last quarter. Capital Research Global Investors grew its stake in shares of Addus HomeCare by 9.0% during the 3rd quarter. Capital Research Global Investors now owns 1,201,560 shares of the company's stock worth $141,772,000 after acquiring an additional 99,262 shares in the last quarter. Wasatch Advisors LP grew its stake in shares of Addus HomeCare by 0.8% during the 3rd quarter. Wasatch Advisors LP now owns 936,243 shares of the company's stock worth $110,467,000 after acquiring an additional 7,089 shares in the last quarter. State Street Corp raised its holdings in shares of Addus HomeCare by 1.3% in the second quarter. State Street Corp now owns 693,368 shares of the company's stock valued at $79,869,000 after purchasing an additional 8,925 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Addus HomeCare by 1.2% in the third quarter. Dimensional Fund Advisors LP now owns 667,256 shares of the company's stock worth $78,729,000 after purchasing an additional 7,884 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.
Addus HomeCare Company Profile
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
